Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis

Multiple Sclerosis and Related Disorders - Tập 50 - Trang 102801 - 2021
Kristin Wesnes1,2,3, Kjell-Morten Myhr1,2, Trond Riise2,4, Silje Stokke Kvistad1,5, Øivind Torkildsen1,2, Stig Wergeland2,6, Trygve Holmøy7,8, Rune Midgard9, Alla Bru10, Astrid Edland11, Randi Eikeland12, Sonia Gosal13, Hanne F. Harbo7,14, Grethe Kleveland15, Yvonne S. Sørenes16, Nina Øksendal17, Kjetil Bjørnevik4
1Department of Clinical Medicine, University of Bergen, Bergen, Norway
2Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway
3Department of Neurology, St Olav’s University Hospital, Trondheim, Norway
4Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
5Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway
6Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway
7Institute of Clinical Medicine, University of Oslo, Oslo, Norway
8Department of Neurology, Akershus University Hospital, Lørenskog, Norway
9Department of Neurology, Molde Hospital, Molde, Norway
10Department of Neurology, Stavanger University Hospital, Stavanger, Norway
11Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway
12Department of Neurology and Department of Paediatrics, Sørlandet Hospital Trust, Arendal, Norway
13Department of Neurology, Østfold Hospital Kalnes, Grålum, Norway
14Department of Neurology, Oslo University Hospital Ullevaal, Oslo, Norway
15Department of Neurology, Innlandet Hospital Lillehammer, Lillehammer, Norway
16Department of Neurology, Haugesund Hospital, Haugesund, Norway
17Department of Neurology, Nordland Hospital Trust, Bodø, Norway

Tài liệu tham khảo

Bove, 2016, Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity, Mult Scler Relat Disord, 8, 136, 10.1016/j.msard.2016.05.019

Brown, 2019, Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis, Jama, 321, 175, 10.1001/jama.2018.20588

Camu, 2019, Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE), Neurol Neuroimmunol Neuroinflamm, 6, 10.1212/NXI.0000000000000597

Cortese, 2020, Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT, Neurology, 94, e1950, 10.1212/WNL.0000000000009371

Claflin, 2018, The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses, Front Neurol, 9, 1150, 10.3389/fneur.2018.01150

Dobson, 2019, Multiple sclerosis - a review, Eur J Neurol, 26, 27, 10.1111/ene.13819

Dardiotis, 2019, Body mass index in patients with Multiple Sclerosis: a meta-analysis, Neurol Res, 41, 836, 10.1080/01616412.2019.1622873

Engelsen, 2005, Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness, Photochem Photobiol, 81, 1287, 10.1562/2004-11-19-RN-375

Hupperts, 2019, Randomized trial of daily high-dose vitamin D-3 in patients with RRMS receiving subcutaneous interferon beta-1a, Neurology, 93, E1906

Hernan, 2005, Cigarette smoking and the progression of multiple sclerosis, Brain, 128, 1461, 10.1093/brain/awh471

Healy, 2009, Smoking and disease progression in multiple sclerosis, Archives of neurology, 66, 858, 10.1001/archneurol.2009.122

Huppke, 2019, Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children, JAMA Neurol, 76, 1157, 10.1001/jamaneurol.2019.1997

Hart, 2011, Modulation of the immune system by UV radiation: more than just the effects of vitamin D?, Nature reviews Immunology, 11, 584, 10.1038/nri3045

Hedstrom, 2009, Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis, Neurology, 73, 696, 10.1212/WNL.0b013e3181b59c40

Habek, 2010, Nutrition in multiple sclerosis, Clin Neurol Neurosurg, 112, 616, 10.1016/j.clineuro.2010.03.029

Koch, 2007, Cigarette smoking and progression in multiple sclerosis, Neurology, 69, 1515, 10.1212/01.wnl.0000277658.78381.db

Kvistad, 2016, No association of tobacco use and disease activity in multiple sclerosis, Neurol Neuroimmunol Neuroinflamm, 3, 10.1212/NXI.0000000000000260

Kvistad, 2015, Body mass index influence interferon-beta treatment response in multiple sclerosis, Journal of neuroimmunology, 288, 92, 10.1016/j.jneuroim.2015.09.008

Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444

Loken-Amsrud, 2012, Vitamin D and disease activity in multiple sclerosis before and during interferon-beta treatment, Neurology, 79, 267, 10.1212/WNL.0b013e31825fdf01

Manouchehrinia, 2013, Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study, Brain, 136, 2298, 10.1093/brain/awt139

Munger, 2015, No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT, Neurology, 85, 1694, 10.1212/WNL.0000000000002099

Mowry, 2018, Body mass index, but not vitamin D status, is associated with brain volume change in MS, Neurology, 91, e2256, 10.1212/WNL.0000000000006644

Martinaityte, 2017, Vitamin D Stored in Fat Tissue During a 5-Year Intervention Affects Serum 25-Hydroxyvitamin D Levels the Following Year, J Clin Endocrinol Metab, 102, 3731, 10.1210/jc.2017-01187

Miclea, 2017, Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity, Brain Behav, 7, e00761, 10.1002/brb3.761

Nortvedt, 2005, Multiple sclerosis and lifestyle factors: the Hordaland Health Study, Neurol Sci, 26, 334, 10.1007/s10072-005-0498-2

Pilutti, 2012, Weight status and disability in multiple sclerosis: An examination of bi-directional associations over a 24-month period, Mult Scler Relat Disord, 1, 139, 10.1016/j.msard.2012.02.004

Pierrot-Deseilligny, 2012, Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation, Ther Adv Neurol Disord, 5, 187, 10.1177/1756285612447090

Prietl, 2013, Vitamin D and immune function, Nutrients, 5, 2502, 10.3390/nu5072502

Ramanujam, 2015, Effect of Smoking Cessation on Multiple Sclerosis Prognosis, JAMA Neurol, 72, 1117, 10.1001/jamaneurol.2015.1788

Smolders, 2019, An Update on Vitamin D and Disease Activity in Multiple Sclerosis, CNS Drugs, 33, 1187, 10.1007/s40263-019-00674-8

2002, Biochemical verification of tobacco use and cessation, Nicotine Tob Res, 4, 149, 10.1080/14622200210123581

Saltyte Benth, 2012, Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients, Neuroepidemiology, 39, 84, 10.1159/000339360

Spelman, 2014, Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Ann Neurol, 76, 880, 10.1002/ana.24287

Torkildsen, 2012, omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial, Archives of neurology, 69, 1044, 10.1001/archneurol.2012.283

2016, Long-term evolution of multiple sclerosis disability in the treatment era, Ann Neurol, 80, 499, 10.1002/ana.24747

Wesnes, 2015, Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study, Mult Scler, 21, 388, 10.1177/1352458514546785

Waubant, 2019, Environmental and genetic risk factors for MS: an integrated review, Ann Clin Transl Neurol, 6, 1905, 10.1002/acn3.50862

Thông tin
Thông tin xuất bản

Multiple Sclerosis and Related Disorders

Tập 50

102801

Thông tin tác giả